243 related articles for article (PubMed ID: 30761438)
1. Is Breast-Conserving Therapy Appropriate for Male Breast Cancer Patients? A National Cancer Database Analysis.
Bateni SB; Davidson AJ; Arora M; Daly ME; Stewart SL; Bold RJ; Canter RJ; Sauder CAM
Ann Surg Oncol; 2019 Jul; 26(7):2144-2153. PubMed ID: 30761438
[TBL] [Abstract][Full Text] [Related]
2. T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis.
Li H; Chen Y; Wang X; Tang L; Guan X
Clin Breast Cancer; 2019 Dec; 19(6):e669-e682. PubMed ID: 31375327
[TBL] [Abstract][Full Text] [Related]
3. Survival following breast-conserving therapy is equal to that following mastectomy in young women with early-stage invasive lobular carcinoma.
Yu TJ; Liu YY; Hu X; Di GH
Eur J Surg Oncol; 2018 Nov; 44(11):1703-1707. PubMed ID: 30029824
[TBL] [Abstract][Full Text] [Related]
4. Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer.
Almahariq MF; Quinn TJ; Siddiqui Z; Jawad MS; Chen PY; Gustafson GS; Dilworth JT
Radiother Oncol; 2020 Jan; 142():186-194. PubMed ID: 31615634
[TBL] [Abstract][Full Text] [Related]
5. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
[TBL] [Abstract][Full Text] [Related]
6. Which eligible breast conservation patients choose mastectomy in the setting of newly diagnosed breast cancer?
Adkisson CD; Bagaria SP; Parker AS; Bray JM; Gibson T; Thomas CS; Heckman MG; McLaughlin SA
Ann Surg Oncol; 2012 Apr; 19(4):1129-36. PubMed ID: 21975859
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of triple-negative versus non-triple-negative breast cancers managed with breast-conserving therapy.
Bhatti AB; Khan AI; Siddiqui N; Muzaffar N; Syed AA; Shah MA; Jamshed A
Asian Pac J Cancer Prev; 2014; 15(6):2577-81. PubMed ID: 24761867
[TBL] [Abstract][Full Text] [Related]
9. Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery.
Orozco JIJ; Keller JK; Chang SC; Fancher CE; Grumley JG
Ann Surg Oncol; 2022 Oct; 29(10):6299-6310. PubMed ID: 35896922
[TBL] [Abstract][Full Text] [Related]
10. Effect of Breast Conservation Therapy vs Mastectomy on Overall Survival and Breast Cancer-Specific Survival Among Men With Stage I-II Breast Cancer: Analysis of SEER, 2000-2018.
He Y; Gao X; Wu J; Li X; Ma Z
Clin Breast Cancer; 2022 Jul; 22(5):410-417. PubMed ID: 35473920
[TBL] [Abstract][Full Text] [Related]
11. Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
Jochelson MS; Lampen-Sachar K; Gibbons G; Dang C; Lake D; Morris EA; Morrow M
Ann Surg Oncol; 2015 May; 22(5):1490-5. PubMed ID: 25777093
[TBL] [Abstract][Full Text] [Related]
12. Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009.
Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Nygård JF
World J Surg Oncol; 2017 Jul; 15(1):118. PubMed ID: 28673296
[TBL] [Abstract][Full Text] [Related]
13. Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status.
Hwang ES; Lichtensztajn DY; Gomez SL; Fowble B; Clarke CA
Cancer; 2013 Apr; 119(7):1402-11. PubMed ID: 23359049
[TBL] [Abstract][Full Text] [Related]
14. In the Modern Treatment Era, Is Breast Conservation Equivalent to Mastectomy in Women Younger Than 40 Years of Age? A Multi-Institution Study.
Frandsen J; Ly D; Cannon G; Suneja G; Matsen C; Gaffney DK; Wright M; Kokeny KE; Poppe MM
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1096-103. PubMed ID: 26581146
[TBL] [Abstract][Full Text] [Related]
15. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer.
Agarwal S; Pappas L; Neumayer L; Kokeny K; Agarwal J
JAMA Surg; 2014 Mar; 149(3):267-74. PubMed ID: 24429935
[TBL] [Abstract][Full Text] [Related]
16. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
17. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
Moran MS; Yang Q; Haffty BG
Breast J; 2009; 15(6):571-8. PubMed ID: 19995377
[TBL] [Abstract][Full Text] [Related]
18. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients.
Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J
Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764
[TBL] [Abstract][Full Text] [Related]
19. Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer.
Mahmood U; Morris C; Neuner G; Koshy M; Kesmodel S; Buras R; Chumsri S; Bao T; Tkaczuk K; Feigenberg S
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1387-93. PubMed ID: 22300561
[TBL] [Abstract][Full Text] [Related]
20. Is Breast Conserving Therapy a Safe Modality for Early-Stage Male Breast Cancer?
Zaenger D; Rabatic BM; Dasher B; Mourad WF
Clin Breast Cancer; 2016 Apr; 16(2):101-4. PubMed ID: 26718092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
